Although revenues still show signs of COVID-19 impact, robotic procedures and implant pull-through accelerate, and companies continue roll out new spine enabling technology and strategize how to maximize the remainder of 2022.
The Q122 WW CAS Spine Market was up year-over-year according to SmartTRAK Financial Dashboard. Medtronic* (MDT) remained the market leader with 59.5% share, followed by Globus* (GMED) and other enabling tech competitors, including Stryker* (SYK) and Brainlab*.
Among the many topics covered in detail in our comprehensive Q122 CAS Spine Market Recap* are: